醫(yī)學(xué)免疫學(xué)英文教學(xué)課件:Chapter 5 Immunoglobulin_第1頁
醫(yī)學(xué)免疫學(xué)英文教學(xué)課件:Chapter 5 Immunoglobulin_第2頁
醫(yī)學(xué)免疫學(xué)英文教學(xué)課件:Chapter 5 Immunoglobulin_第3頁
醫(yī)學(xué)免疫學(xué)英文教學(xué)課件:Chapter 5 Immunoglobulin_第4頁
醫(yī)學(xué)免疫學(xué)英文教學(xué)課件:Chapter 5 Immunoglobulin_第5頁
已閱讀5頁,還剩84頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

1、 Chapter 5 Immunoglobulin(Ig) ContentsIntroductionPart Molecular Structure of IgPart Immunogenicity of IgPart Biological Activity of AbPart Characteristics and Functions of the 5 Classes of IgPart Artificial AbIntroductionAntibody (Ab): Glycoprotein molecules that are produced by plasma cells and ca

2、n combine with the corresponding Ag specifically are called Ab. Ab is produced by B cells in the response to stimulation of Ag. Ab possesses a high degree of specificity and affinity Immunoglobulin(Ig): It refers to all globulins that possess the activity of Ab or show a similar structure to Ab. The

3、refore, All Abs are Igs, but not all Igs possess the functions of Abs.Other ConceptsAntiserum (immune serum) Humoral Immunity sIg(Ab) and mIg(BCR)Part Molecular Structure of Ig Vase. Basic structure Ig is composed of four polypeptide chains joined by disulfide bonds. inter-chain disulfide bonds (S-S

4、) intra-chain disulfide bonds (S-S) It shows “T” or “Y” shape.(four polypeptide chains)1. H and L chain:. Heavy chains (H): 450 550 aa, 50 75 KD. Light chains (L): 214 aa, 25 KD Two terminal ends for each peptide chain “N” terminal end “C” terminal end L chains attach to H chains from “N” end “N” “C

5、”2. Classes and types of Ig (1) According to the differences of H chains (amino acid composition, sequence) Igs can be divided into 5 classes Five classes of H Chain: Five classes of Igs: IgG IgA IgM IgD IgEsubclassesIgG1 IgG4IgA1, IgA2NNCSubclass: According to differences of the amino acid composit

6、ion and number or position of disulfide bonds in hinge region IgG-IgG1,IgG2,IgG3,IgG4 IgA-IgA1,IgA2 (2) According to the differences of L chains Two types of L chain: , : 20:1 (in mice); 2:1 (in human)subtypes 1 43. Two regions of each peptide chain(1) Constant region (C)(3) Hinge region(2) Variable

7、 region (V) (1) Constant region ( C )CH: (,) or 4/5 (,) of H chain from the c end CL: 1/2 of L chain from the c end (2) Variable region ( V )VH: 1/4 (,) or 1/5 (,) of H chain from the N end VL: 1/2 of L chain from the N end 3. Two regions of each peptide chain (2) Variable region ( V ): Hypervariabl

8、e region(HVR) three short stretches in the V region of H and L chains called HVR. Framework region(FR): FR1-FR4Ag-binding sitesComplementarity determining region(CDR)The three HVR of L chain and H chain can be brought together to form antigen-binding surface, so HVR is also called CDR.(2) Variable r

9、egion (V) Complementarity determining region(CDR) L: CDR1, CDR2, CDR3 H: CDR1, CDR2, CDR3 Idiotype of Ig Igs produced by different B cell clones possess unique structure respectively in hypervariable region (HVR), the unique structure of Ig is called idiotype or idiotypic determinant.In fact: HVR CD

10、R Idiotype are in the same sites of Ig (3) Hinge region:Flexible and suitable for CDR of Ig binding to antigenic determinants.Sensitive to proteolytic enzymeOther structures of Ig Joining chain(J) Secretory piece(SP)Joining chain(J) : Produced by plasma cells Functions: linker, to compose dimer, pen

11、tamer or polymer (IgA, IgM)Secretory piece(SP): . Produced by mucosa epithelial cells . Secretory IgA (sIgA) . Functions: protect sIgA, resist proteolysis in extra secretory liquid. Domains of Ig 1. Domain: Polypeptide chains of Ig are folded into a globular structure by intra chain s-s bond within

12、each 110aa region which is called a domain -S-S-CL-S-S-CL-S-S-S-S-CL-S-S-CL-S-S-S-S-CL-S-S-CL-S-S-S-S-S-S-S-S-S-S-CL-S-S-CL-S-S- -S-S-V-S-S-V-S-S-CL-S-S-CL-S-S- -S-S-V-S-S-V-S-S-CL-S-S-CL-S-S-S-S-V-S-S-V-S-S-S-S-S-S-S-S-CLCL-S-S- -S-S-S-S-S-S-CLCL-S-S- -S-S-V-S-S-V-S-S-C2C2-S-S-S-S-C2-S-S-C2-S-S-C2-

13、S-S-C2-S-S-V-S-S-S-S-V-S-S-S-S-C2-S-S-V-S-S-V-S-S-V-S-S-VC2C2-S-S-S-S-C2C2-S-S-S-S-C2C2-S-S-S-S-C2-S-S-C2C2-S-S-S-S-C2C2C2C2C2C2C2-S-S-S-S-S-S-S-S-S-S-S-S-S-S-CD2LAF-3CD3CD4CD8VCAM-1ICAM-1ICAM-2IgR g d eMHC-IMHC-IIb2m (IgM)TCRIga/bIg Superfamily (IgSF)All molecules that contain Ig-like domain belong

14、 to IgSF.2. Domains of IgL chain(2) : VL, CLH chain(45): VH, CH1, CH2, CH3 CH4(IgM,IgE)3. Functions of each domain VH, VL: antigen-binding siteCH, CL: allogeneic markerCH2/CH3: complement-fixing site permeate placenta(IgG) CH3/CH4: cell-binding site . Hydrolytic fragments of IgIg can be digested by

15、papain and pepsinPosition Fragments Functionpapainpepsin1. Digested by papainPosition: near the S-S bonds of H inter-chains from the N end Fragments: 2Fab:fragment of antigen-binding Fc:fragment crystallizable Function: Fab: recognize and bind Ag Fc: (1) fix complement (2) crossing the placenta (3)

16、bind to FcR in different cells papainAg:Ab ratio 2. Digested by pepsinPosition: near the S-S bond of H inter-chains from the C endFragments and function : F(ab)2: bind antigen(2 valence) pFc: no function pepsinSignificance Elucidating the relationships between the structure and function of Igs. Decr

17、ease the immunogenicity of Ig for clinical treatment.Part Immunogenicity of IgIsotype: CH, CLIsotype of antibody:Immunize RabbitMouse IgG1Rabbit anti-mouse IgG1Secondary AbAllotype:CH, CLIdiotype: VH, VLAnti-idiotype antibodyPart Biological Activity of Ab1. Recognize and bind to antigen specifically

18、 2. Fix complement3. Bind to Fc receptor on some cells NeutralizationIgM,IgG13: classical pathwayIgA,IgG4,IgE:alternative pathwayIgG-FcR: FcR(CD64)-phagocyte FcR(CD32)-immune complex FcR(CD16)-NK,macrophage,T cellIgE-FcR: FcR- mast cell, basophil FcR- macrophage, B cellIgA-FcR(CD89)-phagocyte, neutr

19、ophil(1) Opsonization(IgG, IgM): Enhance the phagocytosis of M Opsonization: The process of attaching opsonins(such as IgG and complements) to microbial surfaces to target the microbes for phagocytosis.Opsonins: a macromolecule that attaches to the surface of a microbe and can be recognized by surfa

20、ce receptors of neutrophils and macrophages and that increases the efficiency of phagocytosis of the microbe.(2) ADCC(antibody dependent cell mediated cytotoxicity) ADCCAntibody dependent cell mediated cytotoxicity(ADCC): A process by which NK cells or other cells are targeted to Ig-coated cells, re

21、sulting in lysis of the antibody-coated cells. A specific receptor for the constant region of IgG, called FcR (CD16), is expressed on the NK cell membrane and mediates binding to the IgG. (3) Hypersensitivity type - mast cell, basophil(FcR) FceRIdegranulation IgEallergeninflammationhypersensitivity

22、type I- mast cell and basophils (4) Transfer selectively: .Planceta transfer (IgG) .Mucosa transfer (sIgA)Part Characteristics and Functions of the 5 Classes of Igs . IgG 1. Highest concentration in serum(75% of total Ig) 2. Four subclasses: IgG1, IgG2, IgG3, IgG43. Unique Ig that can pass through p

23、lacenta4. Starts to be produced at 2-3 month after birth and reach the level of adult at 5 years old5. Half-life is longer(16-24 days) 6. Functions of IgG:Against bacteria and virus,neutralize toxinCombine with the Fc receptor(FcR)Activate complementCombine with SPA (Staphylococcal Protein A)Some be

24、long to the auto-antibodiesTake part in type and hypersensitivity. IgM 1. Highest MW:pentamer(90 KD),10 valences 2. Half-life is shorter(45 days)3. The first Ig to be synthesizedAppear in the early stage after infection Be produced during fetusThe first mIg of the B cells, act as the antigen recepto

25、rs(BCR)4. Functions:IgM is more effective in binding Ag and activating C, and play an important role in anti-infectionNatural Ab for blood-type antigen Auto-antibody: rheumatoid factor(RF)Take part in type and hypersensitivity . IgA 1. Two types Serum type :monomer Secretary type(sIgA): dimer,trimer

26、 or polymer2. Two subclasses:IgA1,IgA23. To be produced at 4 months after birth4. Exist in almost all body fluid, rich in colostrum. 6. Local mucosal immunity Immune barrier Neutralize virus/toxin Rich in colostrum (7 days) Activate C by alternative pathway Take part in type hypersensitivity . IgD1.

27、 The concentration in serum is low and sensitive to proteinase2. Act as the antigen receptor on B cells (mIgD): Regulate the differentiation of B cells, the marker of mature B cells. . IgE1.Concerntration of IgE in serum is the lowest in normal individual, but is very high in some patients.2.Related

28、 to typepersensitivity FcR: mast cell, basophil Part Artificial AbPolyclonal AbMonoclonal AbGene engineering Ab1. Polyclonal Ab A mixture Ab with different specificities and affinities Generate in a natural response or artificial immunizationCross reaction 2. Monoclonal Ab (mAb) Ab produced by singl

29、e clone (or one hybridomas clone ) and having a single specificity mAb / McAb Prepared by hybridomas technique: Immunized spleen cells(B) hybride with myeloma cells-hybridomasDefinition: All antibodies which are produced by one B cell clone and only bind to unique antigenic epitope are called monocl

30、onal Ab.Advantage: Identical structure,high fineness,specificity and titerDisadvantage: immunogenecity, cause human anti-mouse antibody(HAMA)Artificial antibodiesDerived from different B Lymphocytes cell linesPOLYCLONAL.MONOCLONAL.Derived from a single B cell cloneBatch to Batch variation affecting

31、Ab reactivity & titremAb offer Reproducible, Predictable & Potentially inexhaustible supply of Ab with exquisite specificityEnable the development of secure immunoassay systems.NOT Powerful tools for clinical diagnostic testsCell fusion technique:Splenocyte(B cell)Myeloma cellHybridoma cellNo AbLong

32、 lifeSecrete AbShort lifeSecrete AbLong lifeKhler and Milstein, 19751984, Nobel Prize1975年Khler和Milstein首先報(bào)道用細(xì)胞雜交技術(shù)將綿羊紅細(xì)胞(SRBC)免疫的小鼠脾細(xì)胞與骨髓瘤細(xì)胞融合,建立起第一個B細(xì)胞雜交瘤細(xì)胞株,并成功地制得抗SRBC的單克隆抗體。 1984年獲得諾貝爾獎雜交瘤細(xì)胞: 骨髓瘤細(xì)胞 無限增殖 B細(xì)胞 合成、分泌特異性抗體雜交瘤技術(shù) : HAT培養(yǎng)基:次黃嘌(H)、氨基蝶呤(A) 和胸腺嘧啶核苷(T)HGPR:次黃嘌呤磷酸核糖轉(zhuǎn)化酶細(xì)胞DNA合成有兩條途徑:主途徑是由糖和氨基酸合成核苷酸,進(jìn)而合成DNA,葉酸作為重要的輔酶參與這一合成過程。另一輔助途徑是在次黃嘌呤和胸腺嘧啶核苷存在的情況下,經(jīng)次黃嘌呤磷酸核糖轉(zhuǎn)化酶(HGPRT)和胸腺嘧啶核苷激酶(TK)的催化作用合成DNA。細(xì)胞融合的選擇培養(yǎng)基中三種關(guān)鍵成分:次黃嘌呤(hypoxanthine,H)、氨甲蝶呤(aminopterin,A)和胸腺嘧啶核苷(thymidine,T),稱為HAT培養(yǎng)基。氨甲蝶呤是葉酸的拮抗劑,可阻斷瘤細(xì)胞利用正常途徑合成DNA,而融合所用的瘤細(xì)胞是經(jīng)毒性培養(yǎng)基選出的HGPRT細(xì)胞株

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論